home / stock / adtx / adtx news


ADTX News and Press, ADiTx Therapeutics Inc. From 07/08/22

Stock Information

Company Name: ADiTx Therapeutics Inc.
Stock Symbol: ADTX
Market: NASDAQ
Website: aditxt.com

Menu

ADTX ADTX Quote ADTX Short ADTX News ADTX Articles ADTX Message Board
Get ADTX Alerts

News, Short Squeeze, Breakout and More Instantly...

ADTX - ORMP, SRAX and RVLP among mid-day movers

Gainers: Seritage Growth Properties ( SRG ) +72% . Aditxt ( ADTX ) +70% . Humanigen ( HGEN ) +35% . Clovis Oncology ( CLVS ) +30% . MyMD Pharmaceuticals ( MYMD ) +27% . Oramed Pharmaceuticals ( ORMP ) +26% . Kura ...

ADTX - Why Is Aditxt (ADTX) Stock Up 74% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aditxt (NASDAQ: ADTX ) stock is soaring 74% to 28 cents in late morning trading on much heavier-than-usual volume. The rally of ADTX was sparked by positive preclinical data reported by the company today. Specific...

ADTX - Researchers Believe Seasonal Allergies Are Worsening

Have you noticed that your pollen allergies are getting worse by the season? You’re not alone. Scientists from Columbia University Irving Medical Center have revealed that outdoor allergies have been getting worse. Physicians across the country say the past few allergy seasons hav...

ADTX - Aditxt stock surges 61% on positive preclinical toxicity study of its psoriasis drug candidate

Aditxt ( NASDAQ: ADTX ) said on Friday that it completed a toxicology study that indicated the safety of its immunotherapeutic technology drug ADI-100, to treat rejection of transplanted organs, skin allografting, autoimmune diseases and allergies. ( ADTX ) stock ...

ADTX - Aditxt, Inc. Successfully Completes Preclinical Toxicity Study of Its Psoriasis Drug Candidate ADI(TM)-100 Advancing it Closer to First-in-Human Trials

Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the "Company"), a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system, today announces that its therapeutic program Adimune™, has successfully c...

ADTX - BioMedNewsBreaks - Aditxt Inc.'s (NASDAQ: ADTX) AditxtScore(TM) Helping Individuals Make More Informed Decisions

Aditxt (NASDAQ: ADTX) recently partnered with Premier Medical Laboratory Services to provide individuals with personalized information regarding their immune system via the AditxtScore(TM). A recent article reads: “The AditxtScore can be used to provide those tested with important a...

ADTX - Virtual Biopsies May Revolutionize Procedures Used in Heart Transplants

Heart transplant patients often undergo cardiac biopsies in the weeks and months after the transplant to check for heart problems and rejection . The procedure, which involves taking a small sample of heart tissue for testing, can be quite invasive. However, thanks to a new technique deve...

ADTX - BioMedNewsBreaks - Aditxt Inc. (NASDAQ: ADTX) Pursuing Strategy Against COVID-19, Immune System-Related Maladies

Aditxt (NASDAQ: ADTX) is focused on developing and commercializing technologies to monitor and reprogram the immune system with the ultimate goal of improving patient outcomes for a variety of conditions. “Aditxt is joining the fight against the pandemic while pursuing a larger stra...

ADTX - Aditxt Inc. (NASDAQ: ADTX) Authorizes New Channel Partner to Offer AditxtScore(TM) Amid Rising COVID-19 Cases and Possible Fall/Winter Waves

Aditxt, Inc. is a is a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system. The Company’s product AditxtScore(TM) is a proprietary immune mapping technology designed to provide a personalized profile of th...

ADTX - Hope of Herd Immunity Dwindles Alongside Federal COVID-19 Budget and Supplies; Aditxt Inc. (NASDAQ: ADTX) and AditxtScore(TM) Could Create Map to COVID-19 Immune Responses

Two years after a vaccine was made available for COVID-19, fewer than 70% of Americans have been vaccinated The AditxtScore(TM) can provide the necessary answers to individualized immune response questions and direct on the best course of treatment for the individual – not the he...

Previous 10 Next 10